Sponsored by
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Risk & Compliance
SEC Charges Former MiMedx Execs With Fraud
The C-suite executives allegedly improperly recognized revenue from distributors with which MiMedx had secret side arrangements.
By
Matthew Heller
| November 27, 2019
Read More
Search
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Sign Up
Sponsored by
Parker Petit
Risk & Compliance
SEC Charges Former MiMedx Execs With Fraud
The C-suite executives allegedly improperly recognized revenue from distributors with which MiMedx had secret side arrangements.
By
Matthew Heller
| November 27, 2019
Read More
People
MiMedx Announces Restatement, Replaces CFO
The biotech firm's stock falls 23% but its CEO says, "It is important that investors understand that our business performance remains strong."
By
Matthew Heller
| June 7, 2018
Read More
